Interestingly, high RBM3 expression is found in poorly differentiated prostate tumor [184], whereas experimental downregulation of RBM3 in prostate cancer cells attenuates cell survival and enhances chemosensitivity in vitro [135]. The gene discussed is RBM3; the disease is prostate cancer.